SVB Wealth’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

SVB Wealth’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-11,000	Closed	-$13K	–	892
2020 Q3	$13K	Buy	+11,000	New	+$11.3K	﹤0.01%	725

Other funds holding INFI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

SVB Wealth's INFI Position: Q4 2020 in Review

SVB Wealth sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2020, closing a stake of 11,000 shares — an estimated $13K sold.

SVB Wealth first reported a position in INFI in Q3 2020 and held it in 1 quarter. The position peaked at $13K in Q3 2020. 55 funds tracked by Wall St. Rank hold INFI as of Q4 2020.

SVB Wealth reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
SVB Wealth sold 11,000 Infinity Pharmaceuticals, Inc. shares in Q4 2020, an estimated $13K.
SVB Wealth first reported a position in Infinity Pharmaceuticals, Inc. in Q3 2020 and held it in 1 quarter.
SVB Wealth's Infinity Pharmaceuticals, Inc. position peaked at $13K in Q3 2020.
55 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2020.

Based on SVB Wealth's 13F filing for Q4 2020, filed 10 Feb 2021.